Hypertensive disorders of pregnancy and severe acute respiratory syndrome coronavirus-2 infection
© 2023 Walter de Gruyter GmbH, Berlin/Boston..
OBJECTIVES: We aimed to determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with an increased risk of hypertensive disorders of pregnancy (HDP).
METHODS: A multicenter retrospective cohort study of all pregnant patients who had SARS-CoV-2 testing and delivered in a large health system between March 2020 and March 2021. Cases were stratified into two groups: patients who tested positive for SARS-CoV-2 during pregnancy vs. patients who tested negative. The primary outcome of HDP, defined as a composite of gestational hypertension, preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome (HELLP Syndrome), and eclampsia by standard criteria, was compared between the two groups. Statistical analysis included multivariable logistic regression to adjust for potential confounders such as maternal demographics and comorbidities. Patient ZIP codes were linked to neighborhood-level data from the US Census Bureau's American Community Survey.
RESULTS: Of the 22,438 patients included, 1,653 (7.4%) tested positive for SARS-CoV-2 infection. Baseline demographics such as age, body mass index, race, ethnicity, insurance type, neighborhood-built environmental and socioeconomic status, nulliparity, and pregestational diabetes differed significantly between the two groups. SARS-CoV- 2 infection in pregnancy was not associated with an increased risk of HDP compared to those without infection (14.9 vs. 14.8%; aOR 1.06 95% CI 0.90-1.24).
CONCLUSIONS: In this large cohort that included a universally-tested population with several socioeconomic indicators, SARS-CoV-2 infection in pregnancy was not associated with an increased risk of HDP.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Journal of perinatal medicine - 51(2023), 5 vom: 27. Juni, Seite 623-627 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wetcher, Cara S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 and pregnancy |
|---|
| Anmerkungen: |
Date Completed 09.06.2023 Date Revised 09.06.2023 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.1515/jpm-2022-0317 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352323787 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352323787 | ||
| 003 | DE-627 | ||
| 005 | 20231226053445.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/jpm-2022-0317 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1174.xml |
| 035 | |a (DE-627)NLM352323787 | ||
| 035 | |a (NLM)36722021 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wetcher, Cara S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hypertensive disorders of pregnancy and severe acute respiratory syndrome coronavirus-2 infection |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.06.2023 | ||
| 500 | |a Date Revised 09.06.2023 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023 Walter de Gruyter GmbH, Berlin/Boston. | ||
| 520 | |a OBJECTIVES: We aimed to determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with an increased risk of hypertensive disorders of pregnancy (HDP) | ||
| 520 | |a METHODS: A multicenter retrospective cohort study of all pregnant patients who had SARS-CoV-2 testing and delivered in a large health system between March 2020 and March 2021. Cases were stratified into two groups: patients who tested positive for SARS-CoV-2 during pregnancy vs. patients who tested negative. The primary outcome of HDP, defined as a composite of gestational hypertension, preeclampsia, hemolysis, elevated liver enzymes, and low platelet count syndrome (HELLP Syndrome), and eclampsia by standard criteria, was compared between the two groups. Statistical analysis included multivariable logistic regression to adjust for potential confounders such as maternal demographics and comorbidities. Patient ZIP codes were linked to neighborhood-level data from the US Census Bureau's American Community Survey | ||
| 520 | |a RESULTS: Of the 22,438 patients included, 1,653 (7.4%) tested positive for SARS-CoV-2 infection. Baseline demographics such as age, body mass index, race, ethnicity, insurance type, neighborhood-built environmental and socioeconomic status, nulliparity, and pregestational diabetes differed significantly between the two groups. SARS-CoV- 2 infection in pregnancy was not associated with an increased risk of HDP compared to those without infection (14.9 vs. 14.8%; aOR 1.06 95% CI 0.90-1.24) | ||
| 520 | |a CONCLUSIONS: In this large cohort that included a universally-tested population with several socioeconomic indicators, SARS-CoV-2 infection in pregnancy was not associated with an increased risk of HDP | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 and pregnancy | |
| 650 | 4 | |a HELLP syndrome | |
| 650 | 4 | |a SARS-CoV-2 and pregnancy | |
| 650 | 4 | |a eclampsia | |
| 650 | 4 | |a hypertensive disorders of pregnancy | |
| 650 | 4 | |a preeclampsia | |
| 700 | 1 | |a Gulersen, Moti |e verfasserin |4 aut | |
| 700 | 1 | |a Rochelson, Burton |e verfasserin |4 aut | |
| 700 | 1 | |a Shan, Weiwei |e verfasserin |4 aut | |
| 700 | 1 | |a Bornstein, Eran |e verfasserin |4 aut | |
| 700 | 1 | |a Blitz, Matthew J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of perinatal medicine |d 1973 |g 51(2023), 5 vom: 27. Juni, Seite 623-627 |w (DE-627)NLM00000636X |x 1619-3997 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2023 |g number:5 |g day:27 |g month:06 |g pages:623-627 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1515/jpm-2022-0317 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2023 |e 5 |b 27 |c 06 |h 623-627 | ||